The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020.
Gloy V, Schmitt AM, Düblin P, Hirt J, Axfors C, Kuk H, Pereira TV, Locher C, Caquelin L, Walter-Claudi M, Lythgoe MP, Herbrand A, Kasenda B, Hemkens LG.
Gloy V, et al. Among authors: kuk h.
Int J Cancer. 2023 Jun 15;152(12):2474-2484. doi: 10.1002/ijc.34473. Epub 2023 Feb 24.
Int J Cancer. 2023.
PMID: 36779785